001448702 000__ 05827cam\a2200553\i\4500
001448702 001__ 1448702
001448702 003__ OCoLC
001448702 005__ 20230310004252.0
001448702 006__ m\\\\\o\\d\\\\\\\\
001448702 007__ cr\cn\nnnunnun
001448702 008__ 220814s2022\\\\si\a\\\\ob\\\\001\0\eng\d
001448702 020__ $$a9789811919466$$q(electronic bk.)
001448702 020__ $$a9811919461$$q(electronic bk.)
001448702 020__ $$z9789811947995
001448702 020__ $$z9811947996
001448702 0247_ $$a10.1007/978-981-19-1946-6$$2doi
001448702 035__ $$aSP(OCoLC)1340946809
001448702 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dOCLCF$$dUKAHL$$dOCLCQ
001448702 049__ $$aISEA
001448702 050_4 $$aRC600
001448702 08204 $$a616.97/8071$$223/eng/20220817
001448702 24500 $$aRole of microorganisms in pathogenesis and management of autoimmune diseases.$$nVolume I,$$pLiver, skin, thyroid, rheumatic & myopathic diseases /$$cMitesh Kumar Dwivedi, N. Amaresan, E. Helen Kemp, Yehuda Shoenfeld, editors.
001448702 24630 $$aLiver, skin, thyroid, rheumatic & myopathic diseases
001448702 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001448702 264_4 $$c©2022
001448702 300__ $$a1 online resource (xix, 680 pages) :$$bcolor illustrations
001448702 336__ $$atext$$btxt$$2rdacontent
001448702 337__ $$acomputer$$bc$$2rdamedia
001448702 338__ $$aonline resource$$bcr$$2rdacarrier
001448702 504__ $$aIncludes bibliographical references and index.
001448702 5050_ $$aPart I: OVERVIEW OF INFECTIOUS MICROORGANISMS & MICROBIOTA IN INDUCING AUTOIMMUNIT -- Chapter 1. The Concept of Infection Triggered autoimmunity -- Chapter 2. The interaction of gut microbiota with immune system and their effects on immune cell development and function -- Chapter 3. The Link between gut microbiota and autoimmune diseases -- Chapter 4. The factors influencing gut microbiota in autoimmune diseases -- PART II: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE LIVER DISEASES -- Chapter 5. Microorganisms in pathogenesis and management of Autoimmune hepatitis (AIH) -- Chapter 6. Microorganisms in pathogenesis and management of Primary Biliary Cholangitis -- Chapter 7. Microorganisms in pathogenesis and management of Primary biliary cholangitis -- PART III: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF SKIN AUTOIMMUNE DISEASES -- Chapter 8. Microorganisms in pathogenesis and management of Psoriasis -- Chapter 9. Microorganisms in pathogenesis and management of Vitiligo -- Chapter 10. Microorganisms in pathogenesis and management of Scleroderma (systemic sclerosis) -- Chapter 11. Microorganisms in pathogenesis and management of Atopic Dermatitis -- Chapter 12. Microorganisms in pathogenesis and management of Pemphigus Vulgaris -- Chapter 13. Microorganisms in pathogenesis and management of Bullous pemphigoid -- PART IV: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE THYROID DISEASES -- Chapter 14. Microorganisms in pathogenesis and management of Graves's Disease -- Chapter 15. Microorganisms in pathogenesis and management of Hashimoto's Thyroiditis -- PART V: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF AUTOIMMUNE RHEUMATIC DISEASES -- Chapter 16. Microorganisms in pathogenesis and management of Rheumatoid Arthritis (RA) -- Chapter 17. Microorganisms in pathogenesis and management of Spondyloarthritis -- Chapter 18. Microorganisms in pathogenesis and management of Ankylosing spondylitis (AS) -- Chapter 19. Microorganisms in pathogenesis and management of Psoriasis Arthritis (PsA) -- Chapter 20. Microorganisms in pathogenesis and management of Systemic Lupus Erythematosus (SLE) -- Chapter 21. Microorganisms in pathogenesis and management of Sjogren⁰́₉s syndrome -- Chapter 22. Autoimmune Diseases Associated with Chikungunya Infection -- PART VI: MICROORGANISMS IN PATHOGENESIS & MANAGEMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES -- Chapter 23. Microorganisms in pathogenesis and management of dermatomyositis (DM) and polymyositis (PM) -- Chapter 24. Microorganisms in pathogenesis and management of necrotizing autoimmune myopathy (NAM) and inclusion body myositis (IBM).
001448702 506__ $$aAccess limited to authorized users.
001448702 520__ $$aThis book in the two volume set provides comprehensive coverage on how microbial pathogens can subvert our immune system into responding against self and resulting into autoimmune diseases. In particular, the book covers the different aspects of linking gut microbiota dysbiosis with autoimmune mechanisms involved in disease development to identify future effective approaches based on the gut microbiota for preventing these autoimmune diseases. Contributions in the book focuses on the role of microbiota/probiotics and their distinct mechanisms exerted in management of autoimmune liver, skin, thyroid, rheumatic and myopathic diseases. This could help in better understanding to design therapeutic strategies that can be deployed to prevent these autoimmune diseases. The book has an interdisciplinary appeal and scholars with an interest immunology, medical microbiology and nutritional sciences will value its contribution. Overall, the book gives a new dimensions and insight in the aspects of microbial role in autoimmune disease pathogenesis and therapeutic aspects.
001448702 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 17, 2022).
001448702 650_0 $$aAutoimmune diseases$$xPathogenesis.
001448702 650_0 $$aAutoimmune diseases$$xTreatment.
001448702 650_0 $$aMicrobial ecology.
001448702 655_0 $$aElectronic books.
001448702 7001_ $$aDwivedi, Mitesh Kumar,$$eeditor.
001448702 7001_ $$aAmaresan, N.,$$eeditor.
001448702 7001_ $$aKemp, E. Helen,$$eeditor.
001448702 7001_ $$aShoenfeld, Yehuda,$$d1948-$$eeditor.
001448702 77608 $$iPrint version: $$z9811947996$$z9789811947995$$w(OCoLC)1302738609
001448702 852__ $$bebk
001448702 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-1946-6$$zOnline Access$$91397441.1
001448702 909CO $$ooai:library.usi.edu:1448702$$pGLOBAL_SET
001448702 980__ $$aBIB
001448702 980__ $$aEBOOK
001448702 982__ $$aEbook
001448702 983__ $$aOnline
001448702 994__ $$a92$$bISE